Key points from article :
Gene therapy study reactivated telomerase gene in cells.
Used an adeno-associated virus (AAV) to deliver the payload.
Study used mouse model that is at high risk of lung cancer.
Did not increase the risk of developing cancer.
Does not integrate into the genomes of the target cells.
Telomerase activation only lasts for a few cell cycles.
Effective against cardiac infarct, aplastic anemia, & pulmonary fibrosis.
The study was published in the journal PLOS Genetics.
